However, researchers concede: “In the present case of 2019-nCoV (COVID-19), virus isolates or samples from infected patients have so far not become available to the international public health community.” In other words, the scientific community did not have a complete virus to use to confirm COVID-19, only a “viral genome sequence,” a snippet of genetic material “very closely related” to COVID-19. That was January 2020. Fast forward to December 2020. The FDA published a guidebook for PCR testing of COVID-19, marked “for emergency use only.” The title of the publication is: CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, and was initially published in February, 2020, and then re-published in July. On page 42 of that document it says this: Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full-length RNA of known titer spiked into a diluent consisting of a suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen. There was still no isolate of the virus months after a pandemic was announced. All laboratories are relying on a provided snippet of RNA genetic material that “mimics” or “is very closely related” to COVID-19.
this is not science folks ~ it’s closer to snake oil ~ oz